Emerging role of G protein-coupled receptors in microvascular myogenic tone

Cardiovascular Research

Volumn 95, Issue 2, 2012, Pages 223-232

  Kauffenstein, Gilles ^a   Laher, Ismail ^b   Matrougui, Khalid ^c   Guérineau, Nathalie C ^a   Henrion, Daniel ^a  

^a UNIVERSITÉ D'ANGERS   (France)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

G protein coupled receptors; G12 13; Gq 11; Myogenic tone; Rho; TRP channels

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID DERIVATIVE; ENDOTHELIN 1; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR G12 13; G PROTEIN COUPLED RECEPTOR Q 11; NUCLEOTIDE; PHOSPHOLIPASE C; RHO FACTOR; SPHINGOSINE 1 PHOSPHATE; THROMBOXANE A2; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG;

BLOOD VESSEL TONE; HUMAN; INTRACELLULAR SIGNALING; MICROVASCULARIZATION; MUSCLE CONTRACTURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MICROVESSELS; MYOCYTES, SMOOTH MUSCLE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84863694429     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs152     Document Type: Review

References (129)

1. Bayliss WM. On the local reactions of the arterial wall to changes of internal pressure. J Physiol 1902;28:220-231.
2. Davis MJ, Hill MA. Signaling mechanisms underlying the vascular myogenic response. Physiol Rev 1999;79:387-423. (Pubitemid 29210926)
3. Loutzenhiser R, Griffin K, Williamson G, Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 2006;290:R1153-R1167.
4. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 2003;65:501-529. (Pubitemid 38249165)
5. Hill MA, Meininger GA, Davis MJ, Laher I. Therapeutic potential of pharmacologically targeting arteriolar myogenic tone. Trends Pharmacological Sci 2009;30:363-374.
6. Mulvany MJ. Small artery remodelling in hypertension. Basic Clin Pharmacol Toxicol 2012;110:49-55.
7. Cipolla MJ, Curry AB. Middle cerebral artery function after stroke: the threshold duration of reperfusion for myogenic activity. Stroke 2002;33:2094-2099. (Pubitemid 34840074)
8. Gschwend S, Henning RH, Pinto YM, de Zeeuw D, van Gilst WH, Buikema H. Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. Br J Pharmacol 2003;139:1317-1325. (Pubitemid 37026415)
9. Harris AK, Elgebaly MM, LiW, Sachidanandam K, Ergul A. Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes. Am J Physiol Regul Integr Comp Physiol 2008;294:R1213-R1219. (Pubitemid 351490640)
10. van den Akker J, Schoorl MJ, Bakker EN, Vanbavel E. Small artery remodeling: current concepts and questions. J Vasc Res 2010;47:183-202.
11. Brayden JE, Earley S, Nelson MT, Reading S. Transient receptor potential (TRP) channels, vascular tone and autoregulation of cerebral blood flow. Clin Exp Pharmacol Physiol 2008;35:1116-1120.
12. Drummond HA, Gebremedhin D, Harder DR. Degenerin/epithelial Na+ channel proteins: components of a vascular mechanosensor. Hypertension 2004;44:643-648. (Pubitemid 39435233)
13. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calciumdependent potassium channels. Science 1992;256:532-535.
14. D'Angelo G, Mogford JE, Davis GE, Davis MJ, Meininger GA. Integrin-mediated reduction in vascular smooth muscle [Ca2+]i induced by RGD-containing peptide. Am J Physiol 1997;272:H2065-H2070.
15. Mogford JE, Davis GE, Platts SH, Meininger GA. Vascular smooth muscle alpha v beta 3 integrin mediates arteriolar vasodilation in response to RGD peptides. Circ Res 1996;79:821-826. (Pubitemid 26317830)
16. Martinez-Lemus LA, Crow T, Davis MJ, Meininger GA. alphavbeta3-and alpha5beta1-integrin blockade inhibits myogenic constriction of skeletal muscle resistance arterioles. Am J Physiol Heart Circ Physiol 2005;289:H322-H329. (Pubitemid 40934117)
17. Wu X, Yang Y, Gui P, Sohma Y, Meininger GA, Davis GE et al. Potentiation of large conductance, Ca2+-activated K+ (BK) channels by alpha5beta1 integrin activation in arteriolar smooth muscle. J Physiol 2008;586:1699-1713. (Pubitemid 351423972)
18. Murphy TV, Spurrell BE, Hill MA. Cellular signalling in arteriolar myogenic constriction: involvement of tyrosine phosphorylation pathways. Clin Exp Pharmacol Physiol 2002;29:612-619. (Pubitemid 34639335)
19. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003;83: 1325-1358. (Pubitemid 37222274)
20. Berridge MJ. Smooth muscle cell calcium activation mechanisms. J Physiol 2008;586: 5047-5061.
21. Nakayama K. Calcium-dependent contractile activation of cerebral artery produced by quick stretch. Am J Physiol 1982;242:H760-H768. (Pubitemid 12040777)
22. Laher I, Bevan JA. Stretch of vascular smooth muscle activates tone and 45Ca2+ influx. J Hypertens Suppl 1989;7:S17-20. (Pubitemid 19265007)
23. Meininger GA, Zawieja DC, Falcone JC, Hill MA, Davey JP. Calcium measurement in isolated arterioles during myogenic and agonist stimulation. Am J Physiol 1991;261: H950-H959.
24. Henrion D, Laher I, Bevan JA. Intraluminal flow increases vascular tone and 45Ca2+ influx in the rabbit facial vein. Circ Res 1992;71:339-345.
25. Laporte R, Haeberle JR, Laher I. Phorbol ester-induced potentiation of myogenic tone is not associated with increases in Ca2+ influx, myoplasmic free Ca2+ concentration, or 20-kDa myosin light chain phosphorylation. J Mol Cell Cardiol 1994; 26:297-302. (Pubitemid 24199290)
26. Eto M, Senba S, Morita F, Yazawa M. Molecular cloning of a novel phosphorylationdependent inhibitory protein of protein phosphatase-1 (CPI17) in smooth muscle: its specific localization in smooth muscle. FEBS Lett 1997;410:356-360. (Pubitemid 27304096)
27. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997;389:990-994. (Pubitemid 27485693)
28. Schubert R, Kalentchuk VU, Krien U. Rho kinase inhibition partly weakens myogenic reactivity in rat small arteries by changing calcium sensitivity. Am J Physiol Heart Circ Physiol 2002;283:H2288-H2295. (Pubitemid 35345932)
29. Chrissobolis S, Sobey CG. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C. Circ Res 2001;88:774-779. (Pubitemid 32429972)
30. Dubroca C, Loyer X, Retailleau K, Loirand G, Pacaud P, Feron O et al. RhoA activation and interaction with Caveolin-1 are critical for pressure-induced myogenic tone in rat mesenteric resistance arteries. Cardiovasc Res 2007;73:190-197. (Pubitemid 44937192)
31. Meininger GA, Faber JE. Adrenergic facilitation of myogenic response in skeletal muscle arterioles. Am J Physiol 1991;260:H1424-H1432.
32. Wirth A, Benyo Z, Lukasova M, Leutgeb B, Wettschureck N, Gorbey S et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for saltinduced hypertension. Nat Med 2008;14:64-68.
33. Davenport AP, D'Orléans-Juste P, Godfraind T, Maguire JJ, Ohlstein EH, Ruffolo RR. Endothelin receptors, introductory chapter. IUPHAR database, http ://wwwiuphar-dborg/DATABASE/FamilyIntroductionForward?familyId=21 2008.
34. Warner TD, de Nucci G, Vane JR. Rat endothelin is a vasodilator in the isolated perfused mesentery of the rat. Eur J Pharmacol 1989;159:325-326. (Pubitemid 19032169)
35. Huang A, Koller A. Endothelin and prostaglandin H2 enhance arteriolar myogenic tone in hypertension. Hypertension 1997;30:1210-1215. (Pubitemid 27476181)
36. Ungvari Z, Koller A. Endothelin and prostaglandin H(2)/thromboxane A(2) enhance myogenic constriction in hypertension by increasing Ca(2+) sensitivity of arteriolar smooth muscle. Hypertension 2000;36:856-861.
37. Sonveaux P, Dessy C, Martinive P, Havaux X, Jordan BF, Gallez B et al. Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Res 2004;64:3209-3214. (Pubitemid 38581424)
38. Cseko C, Bagi Z, Koller A. Biphasic effect of hydrogen peroxide on skeletal muscle arteriolar tone via activation of endothelial and smooth muscle signaling pathways. J Appl Physiol 2004;97:1130-1137. (Pubitemid 39121443)
39. Petersen HH, Choy J, Stauffer B, Moien-Afshari F, Aalkjaer C, Leinwand L et al. Coronary artery myogenic response in a genetic model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol 2002;283:H2244-H2249. (Pubitemid 35345926)
40. Feletou M, Kohler R, Vanhoutte PM. Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets. Curr Hypertens Rep 2010;12:267-275.
41. McGiff JC, Quilley J. 20-HETE and the kidney: resolution of old problems and new beginnings. Am J Physiol 1999;277:R607-R623. (Pubitemid 29458131)
42. Huang A, Sun D, Yan C, Falck JR, Kaley G. Contribution of 20-HETE to augmented myogenic constriction in coronary arteries of endothelial NO synthase knockout mice. Hypertension 2005;46:607-613. (Pubitemid 41376843)
43. Frisbee JC, Roman RJ, Krishna UM, Falck JR, Lombard JH. 20-HETE modulates myogenic response of skeletal muscle resistance arteries from hypertensive Dahl-SS rats. Am J Physiol Heart Circ Physiol 2001;280:H1066-H1074.
44. Chu ZM, Croft KD, Kingsbury DA, Falck JR, Reddy KM, Beilin LJ. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo. Clin Sci (Lond) 2000;98: 277-282. (Pubitemid 30145233)
45. Omura T, Tanaka Y, Miyata N, Koizumi C, Sakurai T, Fukasawa M et al. Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury. Stroke 2006;37:1307-1313. (Pubitemid 43731881)
46. Imig JD, Simpkins AN, Renic M, Harder DR. Cytochrome P450 eicosanoids and cerebral vascular function. Expert Rev Mol Med 2011;13:e7.
47. Gebremedhin D, Lange AR, Narayanan J, Aebly MR, Jacobs ER, Harder DR. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current. J Physiol 1998;507(Pt 3):771-781. (Pubitemid 28143578)
48. Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB et al. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol 1994;266:H2098-H2107.
49. Lange A, Gebremedhin D, Narayanan J, Harder D. 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C. J Biol Chem 1997; 272:27345-27352. (Pubitemid 27452701)
50. Randriamboavonjy V, Busse R, Fleming I. 20-HETE-induced contraction of small coronary arteries depends on the activation of Rho-kinase. Hypertension 2003;41: 801-806. (Pubitemid 36314594)
51. Inoue R, Jensen LJ, Jian Z, Shi J, Hai L, Lurie AI et al. Synergistic activation of vascular TRPC6 channel by receptor and mechanical stimulation via phospholipase C/diacylglycerol and phospholipase A2/omega-hydroxylase/20-HETE pathways. Circ Res 2009;104:1399-1409.
52. Toth P, Rozsa B, Springo Z, Doczi T, Koller A. Isolated human and rat cerebral arteries constrict to increases in flow: role of 20-HETE and TP receptors. J Cereb Blood Flow Metab 2011;31:2096-2105.
53. Feletou M, Vanhoutte PM, Verbeuren TJ. The thromboxane/endoperoxide receptor (TP): the common villain. J Cardiovasc Pharmacol 2010;55:317-332.
54. Szekeres M, Nadasy GL, Kaley G, Koller A. Nitric oxide and prostaglandins modulate pressure-induced myogenic responses of intramural coronary arterioles. J Cardiovasc Pharmacol 2004;43:242-249. (Pubitemid 38129683)
55. Huang A, Sun D, Koller A. Endothelial dysfunction augments myogenic arteriolar constriction in hypertension. Hypertension 1993;22:913-921. (Pubitemid 23358100)
56. Hill MA, Davis MJ, Meininger GA. Cyclooxygenase inhibition potentiates myogenic activity in skeletal muscle arterioles. Am J Physiol 1990;258:H127-H133. (Pubitemid 20063118)
57. Samora JB, Frisbee JC, Boegehold MA. Increased myogenic responsiveness of skeletal muscle arterioles with juvenile growth. Am J Physiol Heart Circ Physiol 2008; 294:H2344-H2351.
58. Spiegel S, Milstien S. Functions of a new family of sphingosine-1- phosphate receptors. Biochim Biophys Acta 2000;1484:107-116. (Pubitemid 30175961)
59. Kostenis E. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for 'old' ligands. J Cell Biochem 2004;92:923-936. (Pubitemid 44264242)
60. Coussin F, Scott RH, Nixon GF. Sphingosine 1-phosphate induces CREB activation in rat cerebral artery via a protein kinase C-mediated inhibition of voltage-gated K+ channels. Biochem Pharmacol 2003;66:1861-1870. (Pubitemid 37249330)
61. Tosaka M, Okajima F, Hashiba Y, Saito N, Nagano T, Watanabe T et al. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 2001;32:2913-2919. (Pubitemid 33134489)
62. Bischoff A, Czyborra P, Fetscher C, Meyer Zu Heringdorf D, Jakobs KH, Michel MC. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol 2000;130:1871-1877. (Pubitemid 30655799)
63. Bolz SS, Vogel L, Sollinger D, Derwand R, Boer C, Pitson SM et al. Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase. Circulation 2003;108:342-347. (Pubitemid 36899027)
64. Hoefer J, Azam MA, Kroetsch JT, Leong-Poi H, Momen MA, Voigtlaender-Bolz J et al. Sphingosine-1-phosphate-dependent activation of p38 MAPK maintains elevated peripheral resistance in heart failure through increased myogenic vasoconstriction. Circ Res 2010;107:923-933.
65. Peter BF, Lidington D, Harada A, Bolz HJ, Vogel L, Heximer S et al. Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone. Circ Res 2008;103:315-324.
66. Praetorius HA, Leipziger J. ATP release from non-excitable cells. Purinergic Signal 2009;5:433-446.
67. Erlinge D, Burnstock G. P2 receptors in cardiovascular regulation and disease. Purinergic Signal 2008;4:1-20.
68. von Kugelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 2006;110:415-432.
69. Robson SC, Sévigny J, Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal 2006;2:409-430.
70. Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, D'Orleans-Juste P et al. NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovasc Res 2010;85:204-213.
71. Vial C, Evans RJ. P2X(1) receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries. Mol Pharmacol 2002;62:1438-1445. (Pubitemid 35403839)
72. Lazarowski ER, Boucher RC, Harden TK. Mechanisms of release of nucleotides and integration of their action as P2X-and P2Y-receptor activating molecules. Mol Pharmacol 2003;64:785-795. (Pubitemid 37153046)
73. Clark MG, Richards SM, Hettiarachchi M, Ye JM, Appleby GJ, Rattigan S et al. Release of purine and pyrimidine nucleosides and their catabolites from the perfused rat hindlimb in response to noradrenaline, vasopressin, angiotensin II and sciatic-nerve stimulation. Biochem J 1990;266:765-770. (Pubitemid 20103710)
74. Koltsova SV, Maximov GV, Kotelevtsev SV, Lavoie JL, Tremblay J, Grygorczyk R et al. Myogenic tone in mouse mesenteric arteries: evidence for P2Y receptor-mediated, Na(+), K (+), 2Cl (2) cotransport-dependent signaling. Purinergic Signal 2009;5: 343-349.
75. Kauffenstein G, Drouin A, Loufrani L, Thorin E, Robaye B, Sevigny J et al. Role of nucleotides, ectonucleotidases and P2 receptors in vascular contraction and myogenic tone. Hypertension 2010;56:1169.
76. Nishida M, Sato Y, Uemura A, Narita Y, Tozaki-Saitoh H, Nakaya M et al. P2Y6 receptor-Galpha12/13 signalling in cardiomyocytes triggers pressure overload-induced cardiac fibrosis. EMBO J 2008;27:3104-3115.
77. Inscho EW, Cook AK, Imig JD, Vial C, Evans RJ. Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 2003;112: 1895-1905. (Pubitemid 38063713)
78. Mederos y Schnitzler M, Storch U, Gudermann T. AT1 receptors as mechanosensors. Curr Opin Pharmacol 2011;11:112-116.
79. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T et al. Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 2004;6:499-506. (Pubitemid 38786592)
80. Mederos y Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A, Essin K et al. Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J 2008;27:3092-3103.
81. Matrougui K, Loufrani L, Heymes C, Levy BI, Henrion D. Activation of AT(2) receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension 1999;34:659-665. (Pubitemid 29496450)
82. Henrion D, Benessiano J, Levy BI. In vitro modulation of a resistance artery diameter by the tissue renin-angiotensin system of a large donor artery. Circ Res 1997;80: 189-195. (Pubitemid 27056982)
83. Muller DN, Fischli W, Clozel JP, Hilgers KF, Bohlender J, Menard J et al. Local angiotensin II generation in the rat heart: role of renin uptake. Circ Res 1998;82:13-20. (Pubitemid 28074014)
84. MaassenVanDenBrink A, de Vries R, Saxena PR, Schalekamp MA, Danser AH. Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase. Cardiovasc Res 1999;44:407-415. (Pubitemid 29474102)
85. Maguire JJ, Davenport AP. Regulation of vascular reactivity by established and emerging GPCRs. Trends Pharmacol Sci 2005;26:448-454. (Pubitemid 41207876)
86. Osol G, Laher I, Kelley M. Myogenic tone is coupled to phospholipase C and G protein activation in small cerebral arteries. Am J Physiol 1993;265:H415-H420. (Pubitemid 23224738)
87. Narayanan J, Imig M, Roman RJ, Harder DR. Pressurization of isolated renal arteries increases inositol trisphosphate and diacylglycerol. Am J Physiol 1994;266: H1840-H1845.
88. Xi Q, Adebiyi A, Zhao G, Chapman KE, Waters CM, Hassid A et al. IP3 constricts cerebral arteries via IP3 receptor-mediated TRPC3 channel activation and independently of sarcoplasmic reticulum Ca2+ release. Circ Res 2008;102:1118-1126. (Pubitemid 351667866)
89. Hofmann T, Obukhov AG, Schaefer M, Harteneck C, Gudermann T, Schultz G. Direct activation of human TRPC6 and TRPC3 channels by diacylglycerol. Nature 1999;397:259-263.
90. Hill MA, Falcone JC, Meininger GA. Evidence for protein kinase C involvement in arteriolar myogenic reactivity. Am J Physiol 1990;259:H1586- H1594. (Pubitemid 20385762)
91. Osol G, Laher I, Cipolla M. Protein kinase C modulates basal myogenic tone in resistance arteries from the cerebral circulation. Circ Res 1991;68:359-367.
92. Laher I, Bevan JA. Protein kinase C activation selectively augments a stretch-induced, calcium-dependent tone in vascular smooth muscle. J Pharmacol Exp Ther 1987;242: 566-572. (Pubitemid 17143490)
93. Earley S, Straub SV, Brayden JE. Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol 2007;292: H2613-H2622. (Pubitemid 47084510)
94. Gudi S, Nolan JP, Frangos JA. Modulation of GTPase activity of G proteins by fluid shear stress and phospholipid composition. Proc Natl Acad Sci USA 1998;95: 2515-2519. (Pubitemid 28145973)
95. Sharif-Naeini R, Folgering JH, Bichet D, Duprat F, Delmas P, Patel A et al. Sensing pressure in the cardiovascular system: Gq-coupled mechanoreceptors and TRP channels. J Mol Cell Cardiol 2009;48:83-89.
96. Massett MP, Ungvari Z, Csiszar A, Kaley G, Koller A. Different roles of PKC and MAP kinases in arteriolar constrictions to pressure and agonists. Am J Physiol Heart Circ Physiol 2002;283:H2282-H2287. (Pubitemid 35345931)
97. Loufrani L, Lehoux S, Tedgui A, Levy BI, Henrion D. Stretch induces mitogenactivated protein kinase activation and myogenic tone through 2 distinct pathways. Arterioscler Thromb Vasc Biol 1999;19:2878-2883. (Pubitemid 30029813)
98. Dubroca C, You D, Levy BI, Loufrani L, Henrion D. Involvement of RhoA/Rho kinase pathway in myogenic tone in the rabbit facial vein. Hypertension 2005;45:974-979. (Pubitemid 40628946)
99. Gohla A, Schultz G, Offermanns S. Role for G(12)/G(13) in agonist-induced vascular smooth muscle cell contraction. Circ Res 2000;87:221-227. (Pubitemid 30626430)
100. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Vaillant N, Gadeau AP, Desgranges C et al. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 2000;278: H1751-H1761. (Pubitemid 30439184)
101. Guilluy C, Bregeon J, Toumaniantz G, Rolli-Derkinderen M, Retailleau K, Loufrani L et al. The Rho exchange factor Arhgef1 mediates the effects of angiotensin II on vascular tone and blood pressure. Nat Med 2010;16:183-190.
102. Lutz S, Freichel-Blomquist A, Yang Y, Rumenapp U, Jakobs KH, Schmidt M et al. The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA. J Biol Chem 2005;280:11134-11139. (Pubitemid 40418419)
103. Wuertz CM, Lorincz A, Vettel C, Thomas MA, Wieland T, Lutz S. p63RhoGEF-a key mediator of angiotensin II-dependent signaling and processes in vascular smooth muscle cells. FASEB J 2010;24:4865-4876.
104. Christensen AP, Corey DP. TRP channels in mechanosensation: direct or indirect activation? Nat Rev Neurosci 2007;8:510-521. (Pubitemid 46985360)
105. Schubert R, Brayden JE. Stretch-activated cation channels and the myogenic response of small arteries. In: Kamkin A, Kiseleva I, eds. Mechanosensitivity in Cells and Tissues. Moscow: Academia, 2005.
106. Sharif-Naeini R, Dedman A, Folgering JH, Duprat F, Patel A, Nilius B et al. TRP channels and mechanosensory transduction: insights into the arterial myogenic response. Pflugers Arch 2008;456:529-540.
107. Earley S, Brayden JE. Transient receptor potential channels and vascular function. Clin Sci (Lond) 2010;119:19-36.
108. Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone of resistance arteries. Circ Res 2002;90:248-250. (Pubitemid 34633924)
109. Dietrich A, Mederos YSM, Gollasch M, Gross V, Storch U, Dubrovska G et al. Increased vascular smooth muscle contractility in TRPC6-/-mice. Mol Cell Biol 2005;25:6980-6989. (Pubitemid 41105898)
110. Gottlieb P, Folgering J, Maroto R, Raso A, Wood TG, Kurosky A et al. Revisiting TRPC1 and TRPC6 mechanosensitivity. Pflugers Arch 2008;455:1097-1103. (Pubitemid 351169977)
111. Reading SA, Earley S, Waldron BJ, Welsh DG, Brayden JE. TRPC3 mediates pyrimidine receptor-induced depolarization of cerebral arteries. Am J Physiol Heart Circ Physiol 2005;288:H2055-H2061. (Pubitemid 40604087)
112. Earley S, Waldron BJ, Brayden JE. Critical role for transient receptor potential channel TRPM4 in myogenic constriction of cerebral arteries. Circ Res 2004;95: 922-929. (Pubitemid 39435007)
113. Nilius B, Prenen J, Tang J, Wang C, Owsianik G, Janssens A et al. Regulation of the Ca2+ sensitivity of the nonselective cation channel TRPM4. J Biol Chem 2005;280: 6423-6433. (Pubitemid 40341189)
114. Vennekens R, Nilius B. Insights into TRPM4 function, regulation and physiological role. Handb Exp Pharmacol 2007:269-285.
115. Sharif-Naeini R, Folgering JH, Bichet D, Duprat F, Lauritzen I, Arhatte M et al. Polycystin-1 and-2 dosage regulates pressure sensing. Cell 2009;139:587-596.
116. Park KS, Kim Y, Lee YH, Earm YE, Ho WK. Mechanosensitive cation channels in arterial smooth muscle cells are activated by diacylglycerol and inhibited by phospholipase C inhibitor. Circ Res 2003;93:557-564. (Pubitemid 37163236)
117. Liu D, Yang D, He H, Chen X, Cao T, Feng X et al. Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats. Hypertension 2009;53:70-76.
118. Ohta T, Morishita M, Mori Y, Ito S. Ca2+ store-independent augmentation of [Ca2+]i responses to G-protein coupled receptor activation in recombinantly TRPC5-expressed rat pheochromocytoma (PC12) cells. Neurosci Lett 2004;358:161-164. (Pubitemid 38368194)
119. Anfinogenova Y, Brett SE,Walsh MP, Harraz OF,Welsh DG. Do TRPC-like currents and G protein-coupled receptors interact to facilitate myogenic tone development? Am J Physiol Heart Circ Physiol 2011;301:H1378-H1388.
120. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS et al. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 1993;72:126-136.
121. Loirand G, Pacaud P. The role of Rho protein signaling in hypertension. Nat Rev Cardiol 2010;7:637-647.
122. Cipolla MJ, Gokina NI, Osol G. Pressure-induced actin polymerization in vascular smooth muscle as a mechanism underlying myogenic behavior. FASEB J 2002;16:72-76. (Pubitemid 34027952)
123. Xu SZ, Muraki K, Zeng F, Li J, Sukumar P, Shah S et al. A sphingosine-1-phosphate-activated calcium channel controlling vascular smooth muscle cell motility. Circ Res 2006;98:1381-1389. (Pubitemid 43948062)
124. Adebiyi A, Zhao G, Narayanan D, Thomas-Gatewood CM, Bannister JP, Jaggar JH. Isoform-selective physical coupling of TRPC3 channels to IP3 receptors in smooth muscle cells regulates arterial contractility. Circ Res 2010;106:1603-1612.
125. Xu SZ, Beech DJ. TrpC1 is a membrane-spanning subunit of storeoperated Ca(2+) channels in native vascular smooth muscle cells. Circ Res 2001;88:84-87. (Pubitemid 32064087)
126. Dietrich A, Kalwa H, Storch U, Mederos y Schnitzler M, Salanova B, Pinkenburg O et al. Pressure-induced and store-operated cation influx in vascular smooth muscle cells is independent of TRPC1. Pflugers Arch 2007;455:465-477. (Pubitemid 47624204)
127. Alvarez J, Coulombe A, Cazorla O, Ugur M, Rauzier JM, Magyar J et al. ATP/UTP activate cation-permeable channels with TRPC3/7 properties in rat cardiomyocytes. Am J Physiol Heart Circ Physiol 2008;295:H21-H28.
128. Spassova MA, Hewavitharana T, Xu W, Soboloff J, Gill DL. A common mechanism underlies stretch activation and receptor activation of TRPC6 channels. Proc Natl Acad Sci USA 2006;103:16586-16591. (Pubitemid 44715239)
129. Earley S, Reading S, Brayden JE. Functional Significance of Transient Receptor Potential Channels in Vascular Function. Liedtke WB, Heller S, eds. Frontiers in Bioscience CRC Press. 2007; ch. 26.